CAS: 123387-72-4; Tert-Butyl Methyl(2-Oxoethyl)Carbamate

相似化合物

89711-08-0 156939-62-7 125969-54-2

上下游产品

叔丁氧羰酰基肌氨酸 N-(Tert-Butoxycarbonyl)Sarcosine 13734-36-6
2-(N-Boc-N-甲基氨基)乙醇 Methyl(2-Hydroxyethyl)Carbamic Acid Tert-Butyl Ester 57561-39-4
Boc-肌氨酸甲酯 Methyl 2-((Tert-Butoxycarbonyl)(Methyl)Amino)Acetate 42492-57-9
Boc-甘氨酸 Boc-Glycine 4530-20-5
椰油基二甲基叔胺 Tert-Butyl N,N-Dimethylcarbamate 7541-17-5
Tert-Butyl (2,3-Dihydroxypropyl)Methylcarbamate 179053-13-5
甲基-氨基甲酸叔丁酯 N-(Tert-Butoxycarbonyl)Methylamine 16066-84-5
Tert-Butyl N-[2-[methoxy(Methyl)Amino]-2-Oxoethyl]-N-Methylcarbamate 140170-90-7

叔丁氧羰酰基肌氨酸置于n-甲基吗啉,Lithium Aluminium Tetrahydride,氯甲酸异丁酯体系中,用 四氢呋喃,二氯甲烷 用作溶剂,化学反应 16.58H,反应生成N-Boc-(甲胺基)乙醛
参考文献:Fused And Bridged Bi-And Tri-Cyclic Lactams Via Sequential Metallo-Azomethine Ylide Cycloaddition-lactamisation
标题:Fused And Bridged Bi-And Tri-Cyclic Lactams Via Sequential Metallo-Azomethine Ylide Cycloaddition-lactamisation
摘要:Aldimines Of A-Amino Esters Derived From Aldehydes Bearing An Alpha-,Beta-Or Gamma-Protected Amino Group Undergo Agoac/r3N Catalysed Cycloaddition To Electronegative Olefins (Dipolarophile). Subsequent Unmasking Of The Amino Group And Lactamisation,Spontaneous In Most Cases,Generates 5-7 Membered Fused And Bridged Bi-And Tri-Cyclic Lactams. The Regioselectivity Of The Lactamisation Is Controlled By Appropriate Choice Of The Dipolarophile. (C) 2002 Elsevier Science Ltd. All Rights Reserved.
Doi:10.1016/s0040-4020(02)00029-7

专利信息

专利号:RU-2092491-C1
优先权日:1990-05-14
标 题 :Peptide derivatives or their pharmaceutically acceptable salts, method of synthesis of peptide derivatives and pharmaceutical composition

专利号:US-7989438-B2
优先权日:2007-07-17
标题 :Therapeutic compounds
发明人：CONTE IMMACOLATA; HABERMANN JOERG; MACKAY ANGELA; NARJES FRANK; RICO FERREIRA MARIA DEL ROSARIO; STANSFIELD IAN
权利人:ANGELETTI P IST RICHERCHE BIO
摘要:A class of macrocyclic compounds of formula (I), wherein R 7 , A, Ar, B, D, F, M, Q 1 , Q 2 , W, X, Y and Z are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection.

专利号:US-2025276972-A1
优先权日:2020-12-15
标 题:Compounds as casein kinase inhibitors
发明人：Zhou Enxing; LIU YUAN; WANG HANPING; WU GUANGLONG; SHAO NING
权利人:GRITSCIENCE BIOPHARMACEUTICALS CO LTD
摘要:Provided are casein kinase inhibitors, or pharmaceutically acceptable salts thereof. Corresponding pharmaceutical compositions, methods of synthesis, and intermediates are also provided.

专利号:CN-105017219-A
优先权日:2015-07-13
标 题:A kind of synthesis method of p53-MDM2 binding inhibitor dihydroxyisoquinoline derivative